Vestibular Schwannomas Unilateral vestibular schwannomas have a lifetime prevalence
exceeding 1 case per 500 persons. The unpredictable clinical behavior of these tumors and …

This article describes various epidemiologic trends for vestibular schwannomas over the last
35 years and includes a brief note on terminology. Knowledge of the spontaneous course or …

Vestibular schwannomas have been traditionally managed with microsurgical removal and
in recent years, stereotactic radiotherapy. However, there is a group of patients in whom a …

Object There are a variety of treatment options for the management of vestibular
schwannomas (VSs), including microsurgical resection, radiotherapy, and observation …

BACKGROUND: One hundred ninety-three patients with sporadic unilateral vestibular
schwannoma given conservative management were enrolled in a prospective study …

Sporadic vestibular schwannoma (VS) causes unilateral hearing loss, tinnitus, vertigo and
unsteadiness. In many cases, the tumour size may remain unchanged for many years …

Objectives: Stimulated by the availability of a larger sample of patients and a longer follow‐
up period, we update our experience with conservative management of vestibular …

Objective Reports on the epidemiology of vestibular schwannoma (VS) indicate an increase
in diagnosed cases, often based on selected materials over a limited period of time. This …

Although microsurgery is generally regarded as the conventional treatment of choice for
most vestibular schwannomas, there remains a group of patients in whom a conservative …

Objective: To determine the natural history and long-term quality-of-life (QOL) outcome after
conservative treatment for vestibular schwannoma. Study Design: Prospective study …